COVID-19 (severe/critical) |
Comorbidities |
Diabetes [Present vs. Not present] |
Odds ratio: 1.950 (0.630-5.990)
|
Chen
|
|
|
COVID-19 (severe/critical) |
Comorbidities |
Hypertension [Present vs. Not present] |
Odds ratio: 2.590 (0.610-10.980)
§ |
Chen
|
|
|
COVID-19 (severe/critical) |
Patient characteristics |
Gender [Male vs. Female] |
Odds ratio: 4.280 (0.860-21.210)
§ |
Chen
|
|
|
COVID-19 (severe/critical) |
Patient characteristics |
Age [1 year increase vs. Not applicable] |
Odds ratio: 1.020 (0.960-1.080)
§ |
Chen
|
|
|
COVID-19 (severe/critical) |
Laboratory Findings |
HS-cTnI [Abnormal vs. Normal] |
Hazard ratio: 10.900 (1.280-92.930)
§ |
Zhang
|
|
|
COVID-19 (severe/critical) |
Laboratory Findings |
D-dimer [1 unit increase vs. Not applicable] |
Hazard ratio: 1.100 (1.030-1.180)
§ |
Zhang
|
|
|
COVID-19 (severe/critical) |
Laboratory Findings |
Creatinine [Abnormal vs. Normal] |
Hazard ratio: 1.001 (0.999-999.990)
§ |
Zhang
|
|
|
COVID-19 (severe/critical) |
Laboratory Findings |
Oxygen Saturation (SpO2) [Abnormal vs. Normal] |
Hazard ratio: 0.700 (0.550-0.910)
§ |
Zhang
|
|
|
COVID-19 (severe/critical) |
Patient characteristics |
Age [1 year increase vs. Not applicable] |
Hazard ratio: 1.010 (0.940-1.090)
§ |
Zhang
|
|
|
COVID-19 (severe/fatal) |
Laboratory Findings |
Neutrophils [Abnormal vs. Normal] |
Odds ratio: 5.930 (2.300-15.290)
§ |
Hu
|
|
|
COVID-19 (severe/fatal) |
Laboratory Findings |
WBC [Abnormal vs. Normal] |
Odds ratio: 10.850 (3.040-38.750)
§ |
Hu
|
|
|
COVID-19 (severe/fatal) |
Laboratory Findings |
Hs-TnI [Abnormal vs. Normal] |
Odds ratio: 4.390 (1.260-15.270)
§ |
Hu
|
|
|
COVID-19 (severe/fatal) |
Comorbidities |
Diabetes [Present vs. Not present] |
Odds ratio: 3.110 (1.160-8.370)
§ |
Hu
|
|
|
COVID-19 (severe/fatal) |
Status |
Diagnosis at critical status [Present vs. Not present] |
Odds ratio: 7.390 (2.060-26.570)
§ |
Hu
|
|
|
COVID-19 (severe/fatal) |
Treatment |
Treatment for COVID-19 [Treated with hypnotics vs. Not received] |
Odds ratio: 0.080 (0.030-0.270)
§ |
Hu
|
|
|
COVID-19 (severe/fatal) |
Patient characteristics |
Smoking [Present vs. Not present] |
Odds ratio: 3.460 (1.180-10.170)
§ |
Hu
|
|
|
COVID-19 (severe/fatal) |
Patient characteristics |
Age [>=65 years vs. < 65 years] |
Odds ratio: 3.550 (1.630-7.730)
§ |
Hu
|
|
|
COVID-19 (severe/critical) |
Laboratory Findings |
Cardiac troponin [1 unit increase vs. Normal] |
Odds ratio: 26.910 (4.090-177.230)
§ |
Chen
|
|
|
COVID-19 (severe/critical) |
Comorbidities |
Coronary heart disease [Present vs. Not present] |
Odds ratio: 16.610 (2.290-120.580)
§ |
Chen
|
|
|
COVID-19 (death) |
Complications |
Cardiac injury [Present vs. Not present] |
Hazard ratio: 1.550 (0.750-3.190)
§ |
Wang
|
|
|
COVID-19 (death) |
Comorbidities |
COPD [Present vs. Not present] |
Hazard ratio: 2.240 (1.120-4.500)
§ |
Wang
|
|
|
COVID-19 (death) |
Comorbidities |
Cerebrovascular disease [Present vs. Not present] |
Hazard ratio: 1.380 (0.650-2.930)
§ |
Wang
|
|
|
COVID-19 (death) |
Comorbidities |
Cardiovascular disease [Present vs. Not present] |
Hazard ratio: 1.860 (1.060-3.260)
§ |
Wang
|
|
|
COVID-19 (death) |
Symptoms |
Dyspnea [Present vs. Not present] |
Hazard ratio: 2.350 (1.430-3.870)
|
Wang
|
|
|
SARS COV-2 infection |
Patient characteristics |
Hand hygiene [Suboptimal hand hygiene after contact with patients vs. No] |
Relative risk: 2.430 (1.340-4.390)
|
Ran
|
|
|
SARS COV-2 infection |
Patient characteristics |
Hand hygiene [Suboptimal hand hygiene before contact patients vs. No] |
Relative risk: 3.100 (1.430-6.730)
|
Ran
|
|
|
SARS COV-2 infection |
Patient characteristics |
Unqualified hand-washing [Unqualified hand-washing vs. No] |
Risk ratio: 2.640 (1.040-6.710)
|
Ran
|
|
|
SARS COV-2 infection |
Patient characteristics |
Medical operation and protection [Performed sputum suction vs. Did not perform sputum suction] |
Relative risk: 0.430 (0.120-1.550)
|
Ran
|
|
|
SARS COV-2 infection |
Patient characteristics |
Medical operation and protection [High exposure operation vs. Not high exposure operation] |
Relative risk: 0.540 (0.190-1.530)
|
Ran
|
|
|
SARS COV-2 infection |
Patient characteristics |
Contact history [With contact to Huanan seafood market vs. Without contact to Huanan seafood market] |
Relative risk: 0.630 (0.060-7.080)
|
Ran
|
|
|
SARS COV-2 infection |
Patient characteristics |
Contact history [With contact to suspected patient vs. Without contact to suspected patient] |
Relative risk: 0.490 (0.270-0.890)
† |
Ran
|
|
|
SARS COV-2 infection |
Patient characteristics |
Contact history [With contact to diagnosed patient vs. Without contact to diagnosed patient] |
Relative risk: 0.360 (0.220-0.590)
† |
Ran
|
|
|
SARS COV-2 infection |
Patient characteristics |
Contact history [With suspected family member vs. Without suspected family member] |
Relative risk: 1.300 (0.310-5.350)
|
Ran
|
|
|
SARS COV-2 infection |
Patient characteristics |
Contact history [With diagnosed family member vs. Without diagnosed family member] |
Relative risk: 2.760 (2.020-3.770)
|
Ran
|
|
|
COVID-19 (death) |
Laboratory Findings |
Procalcitonin [Abnormal vs. Normal] |
Odds ratio: 9.330 (0.960-90.630)
§ |
Chen
|
|
|
COVID-19 (death) |
Laboratory Findings |
CRP [Abnormal vs. Normal] |
Odds ratio: 1.010 (0.980-1.040)
§ |
Chen
|
|
|
COVID-19 (death) |
Laboratory Findings |
LDH [Abnormal vs. Normal] |
Odds ratio: 1.020 (0.990-1.030)
§ |
Chen
|
|
|
COVID-19 (death) |
Laboratory Findings |
Creatinine [Abnormal vs. Normal] |
Odds ratio: 4.820 (1.160-16.960)
§ |
Chen
|
|
|
COVID-19 (death) |
Laboratory Findings |
AST [Abnormal vs. Normal] |
Odds ratio: 2.040 (0.560-7.380)
§ |
Chen
|
|
|
COVID-19 (death) |
Status |
Time from symptom onset to hospital admission [1 day increase vs. Not applicable] |
Odds ratio: 0.660 (0.470-0.910)
§ |
Chen
|
|
|
COVID-19 (death) |
Symptoms |
Shortness of breath [Present vs. Not present] |
Odds ratio: 12.900 (1.800-94.400)
§ |
Chen
|
|
|
COVID-19 (death) |
Comorbidities |
Any comorbidity [Present vs. Not present] |
Odds ratio: 16.100 (1.900-133.800)
§ |
Chen
|
|
|
COVID-19 (death) |
Patient characteristics |
Gender [Male vs. Female] |
Odds ratio: 13.800 (1.410-136.100)
§ |
Chen
|
|
|
COVID-19 (severe/fatal) |
Comorbidities |
No. of comorbidities [With 2 or more comorbidities vs. Not present] |
Hazard ratio: 2.590 (1.610-4.170)
§ |
Guan
|
|
|
COVID-19 (severe/critical) |
Comorbidities |
No. of comorbidities [With one comorbidity vs. Not present] |
Hazard ratio: 1.790 (1.160-2.770)
§ |
Guan
|
|
|
COVID-19 (severe/critical) |
Comorbidities |
Cancer [Present vs. Not present] |
Hazard ratio: 3.500 (1.600-7.640)
§ |
Guan
|
|
|
COVID-19 (severe/critical) |
Comorbidities |
Hypertension [Present vs. Not present] |
Hazard ratio: 1.580 (1.070-2.320)
§ |
Guan
|
|
|
COVID-19 (severe/critical) |
Comorbidities |
Diabetes [Present vs. Not present] |
Hazard ratio: 1.590 (1.030-2.450)
§ |
Guan
|
|
|
COVID-19 (severe/critical) |
Comorbidities |
COPD [Present vs. Not present] |
Hazard ratio: 2.680 (1.420-5.050)
§ |
Guan
|
|
|
SARS COV-2 infection |
Patient characteristics |
Gender [Male vs. Female] |
Odds ratio: 3.670 (1.030-14.120)
§ |
Sun
|
|
|